Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03214640 · ClinicalTrials.gov registry record · NA
Rivanna Ultrasound for Neuraxial Block
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 128
- Enrollment target
NCT03214640 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 128 participants.
The verdict
NCT03214640, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
Study Summary
We hypothesize that the Rivanna Accuro or similar U/S device would reduce time to success of identifying epidural and/or intrathecal spaces as compared to conventional palpation method.
Interventions
- OTHER Palpation
- DEVICE Rivanna Accuro US Device
- PROCEDURE Neuraxial Analgesia
- PROCEDURE Spinal Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2017-10-23 |
| Est. Completion | 2019-04-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03214640
The ClinicalTrials.gov registry entry for NCT03214640 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Palpation is the first listed.
NCT03214640 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03214640 about?
NCT03214640 is a clinical study titled "Rivanna Ultrasound for Neuraxial Block". We hypothesize that the Rivanna Accuro or similar U/S device would reduce time to success of identifying epidural and/or intrathecal spaces as compared to conventional palpation method.
What is the current status of trial NCT03214640?
This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2017-10-23. Estimated completion is 2019-04-13.
What interventions are being tested in trial NCT03214640?
The interventions under investigation include: Palpation (OTHER), Rivanna Accuro US Device (DEVICE), Neuraxial Analgesia (PROCEDURE), Spinal Block (PROCEDURE).
Who is sponsoring clinical trial NCT03214640?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.